An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling

被引:6
|
作者
Hunt, Brian G. [1 ]
Fox, Levi H. [1 ]
Davis, James C. [1 ]
Jones, Angelle [1 ]
Lu, Zhixin [1 ]
Waltz, Susan E. [1 ,2 ]
机构
[1] Univ Cincinnati, Dept Canc Biol, Coll Med, Cincinnati, OH 45267 USA
[2] Cincinnati Vet Affairs Hosp, Res Serv, Med Ctr, Cincinnati, OH 45220 USA
基金
美国国家卫生研究院;
关键词
RON receptor; MST1R; HGFL; macrophage stimulating protein; receptor tyrosine kinase; MACROPHAGE-STIMULATING PROTEIN; DEPENDENT GENE-REGULATION; IFN-GAMMA PRODUCTION; SHORT-FORM RON; BREAST-CANCER; BETA-CATENIN; PHOSPHATIDYLINOSITOL-3; KINASE; PERITONEAL-MACROPHAGES; CELL ADHESION; ACTIVATION;
D O I
10.3390/genes14020517
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
RON is a receptor tyrosine kinase (RTK) of the MET receptor family that is canonically involved in mediating growth and inflammatory signaling. RON is expressed at low levels in a variety of tissues, but its overexpression and activation have been associated with malignancies in multiple tissue types and worse patient outcomes. RON and its ligand HGFL demonstrate cross-talk with other growth receptors and, consequentially, positions RON at the intersection of numerous tumorigenic signaling programs. For this reason, RON is an attractive therapeutic target in cancer research. A better understanding of homeostatic and oncogenic RON activity serves to enhance clinical insights in treating RON-expressing cancers.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Receptor tyrosine kinase signaling in vascular development
    Merenmies, J
    Parada, LF
    Henkemeyer, M
    CELL GROWTH & DIFFERENTIATION, 1997, 8 (01): : 3 - 10
  • [42] Ligand bias in receptor tyrosine kinase signaling
    Karl, Kelly
    Paul, Michael D.
    Pasquale, Elena B.
    Hristova, Kalina
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (52) : 18494 - 18507
  • [43] Accounting for specificity in receptor tyrosine kinase signaling
    Madhani, HD
    CELL, 2001, 106 (01) : 9 - 11
  • [44] Quantification of receptor tyrosine kinase signaling.
    Kholodenko, BN
    Hoek, JB
    FASEB JOURNAL, 2000, 14 (08): : A1314 - A1314
  • [45] Demethylating therapy modulates expression of the RON tyrosine kinase receptor in pancreatic cancer
    Chakedis, Jeffery
    French, Randall
    Jaquish, Dawn
    Mose, Evangeline
    Lowy, Andrew
    CANCER RESEARCH, 2014, 74 (19)
  • [46] RON IS A HETERODIMERIC TYROSINE KINASE RECEPTOR-ACTIVATED BY THE HGF HOMOLOG MSP
    COMOGLIO, PM
    FOLLENZI, A
    NALDINI, L
    COLLESI, C
    SANTORO, M
    GALLO, KA
    GODOWSKI, PJ
    GAUDINO, G
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 13 - 13
  • [47] Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers
    Ming-hai Wang
    Hang-ping Yao
    Yong-qing Zhou
    Acta Pharmacologica Sinica, 2006, 27 : 641 - 650
  • [48] MenaINV dysregulation of receptor tyrosine kinase signaling
    Oudin, Madeleine J.
    Hughes-Alford, Shannon K.
    Miller, Miles
    Asokan, Sreeja B.
    Bear, James E.
    Lauffenburger, Doug A.
    Gertier, Frank B.
    CANCER RESEARCH, 2013, 73
  • [49] The role of the RON receptor tyrosine kinase in a murine model of fulminant hepatic failure
    Leonis, MA
    Waltz, SE
    Degen, SJF
    GASTROENTEROLOGY, 2001, 120 (05) : A28 - A28
  • [50] Met-related receptor tyrosine kinase Ron in tumor growth and metastasis
    Wagh, Purnima K.
    Peace, Belinda E.
    Waltz, Susan E.
    ADVANCES IN CANCER RESEARCH, VOL 100, 2008, 100 : 1 - +